ARS Pharmaceuticals, Inc. (SPRY) Operating margin 2021–2025
ARS Pharmaceuticals, Inc. (SPRY) operating margin by fiscal year — reported operating income divided by reported revenue.
-212.9%FY2025 · since FY2021: -353.3% → -212.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -212.9% | -209.5 pp |
| FY2024 | -3.5% | +225063.2 pp |
| FY2023 | -225066.7% | -222367.9 pp |
| FY2022 | -2698.8% | -2345.5 pp |
| FY2021 | -353.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice